Thermo Fisher Bioproduction Insights

  1. Integrated AEX And SPTFF Processing Using A Single Automated Workflow 8/20/2026

    See how integrating AEX flow-through chromatography with inline SPTFF concentration can reduce intermediate handling and process transitions while maintaining polishing performance.

  2. Reliable Mixing Across Changing Batch Volumes 8/20/2026

    See how working volume and agitation speed influence mixing, with practical performance data to help teams assess efficiency across a broad range of upstream and downstream operating conditions.

  3. Improving AAV Manufacturing: Advancements In Full Capsid Enrichment 8/19/2026

    As AAV manufacturing matures, integrated optimization of capture, buffer chemistry, load conditioning, and AEX polishing enables scalable full capsid enrichment, improving product quality and manufacturability.

  4. Secure Your Custom Media Supply With Capacity And Quality You Can Trust 7/17/2026

    A resilient media supply strategy helps reduce operational risk. Gain insight into how scalable manufacturing, quality alignment, and supplier qualification can strengthen continuity.

  5. Is It Better To Scale Up Or Scale Out Your Cell Culture Platform? 6/29/2026

    Take a look at how adherent cell culture expansion affects space, labor, costs, contamination risk, and sustainability, helping teams weigh when a larger-footprint approach stops making sense.

  6. Engineering The Future Of Antibody-Drug Conjugates 6/26/2026

    As ADCs expand into broader use, upstream process design is becoming a competitive advantage. Discover how smarter media strategies and data-driven decision-making are helping teams reduce risk.

  7. Q&A: From Trial-And-Error To Predictive Protein Production 6/26/2026

    Speed in protein production starts with better inputs and stronger process analytics. Learn how a three-part strategy helps teams reduce rework and move from guesswork to predictable outcomes.

  8. Exploring The Future Of Cell Expansion In Cell Therapy Manufacturing 6/26/2026

    As cell therapy scales, success depends on more than clinical promise. Smarter expansion strategies, automation, and flexible manufacturing platforms are becoming critical for improving consistency.

  9. Delivering Critical Therapies With Speed And Safety 6/26/2026

    Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.

  10. A Clear Path To Rapid, Consistent Biosimilar Development 6/23/2026

    Faster timelines don’t have to come at the expense of quality or consistency. Discover proven strategies to generate stable, high-performing cell lines while reducing risk and supporting reliable scale-up.